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Abstract
Background: Uncertainty exists about benefits and harms of a planned vaginal birth after caesarean (VBAC) compared with
elective repeat caesarean (ERC). We conducted a prospective restricted cohort study consisting of a patient preference
cohort study, and a small nested randomised trial to compare benefits and risks of a planned ERC with planned VBAC.
Methods and findings: 2,345 women with one prior caesarean, eligible for VBAC at term, were recruited from 14 Australian
maternity hospitals. Women were assigned by patient preference (n=2,323) or randomisation (n=22) to planned VBAC
(1,225 patient preference, 12 randomised) or planned ERC (1,098 patient preference, ten randomised). The primary outcome
was risk of fetal death or death of liveborn infant before discharge or serious infant outcome. Data were analysed for the
2,345 women (100%) and infants enrolled. The risk of fetal death or liveborn infant death prior to discharge or serious
infant outcome was significantly lower for infants born in the planned ERC group compared with infants in the planned
VBAC group (0.9% versus 2.4%; relative risk [RR] 0.39; 95% CI 0.19–0.80; number needed to treat to benefit 66; 95% CI 40–
200). Fewer women in the planned ERC group compared with women in the planned VBAC had a major haemorrhage
(blood loss $1,500 ml and/or blood transfusion), (0.8% [9/1,108] versus 2.3% [29/1,237]; RR 0.37; 95% CI 0.17–0.80).
Conclusions: Among women with one prior caesarean, planned ERC compared with planned VBAC was associated with a
lower risk of fetal and infant death or serious infant outcome. The risk of major maternal haemorrhage was reduced with no
increase in maternal or perinatal complications to time of hospital discharge. Women, clinicians, and policy makers can use
this information to develop health advice and make decisions about care for women who have had a previous caesarean.
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Caesarean section is one of the commonest operations
performed on childbearing women, with rates continuing to rise
worldwide. For women who have had a previous caesarean,
choices for mode of birth in their next pregnancy are either a trial
of vaginal birth after caesarean (VBAC) or an elective repeat
caesarean (ERC). For women who attempt a VBAC, the chance of
achieving vaginal birth has been variably reported between 56%
[1] and 80% [2]. The proportion of women attempting a VBAC
has been declining in many countries [3], fuelled by negative
reports of an increase in the risk of maternal and infant
complications related to VBAC [4], including uterine rupture
[5] and perinatal death [6]. The rates of repeat caesarean birth
following a previous caesarean have risen commensurately,
reaching 83% in Australia [7] and almost 90% in the US [3].
Repeat caesarean now accounts for 28% of all births in the United
Kingdom [8].
Both ERC and VBAC have benefits and harms. Risks of
planned VBAC when compared with planned ERC include
haemorrhage, need for blood transfusion, endometritis, uterine
rupture, perinatal death, and hypoxic ischaemic encephalopathy
[8–12]. By comparison, women planning ERC are at increased
risk of surgical complications, placenta accreta, and risks of
multiple caesareans [11] and their infants are at risk of respiratory
morbidity [10,11]. Couples may experience subsequent infertility.
[9–12].
There have been no randomised controlled trials comparing
health outcomes after VBAC and ERC although the difficulty of
conducting such trials has been recognised [9,11]. A comprehen-
sive systematic review of the nonrandomised literature comparing
ERC with VBAC concluded that the current literature was
‘‘significantly flawed,’’ and that future research ‘‘should focus on
comparability of the groups, specificity of the intervention, and
standard outcome measures.’’ [10]. The need for evidence to
inform women, clinicians, and policy makers about health
outcomes of intended planned mode of birth rather than actual
has been highlighted as critical [11]. To address these research
gaps we conducted a prospective restricted cohort study that
became effectively a patient preference study, with a smaller
randomised trial (Text S1) [13] to compare the benefits and risks
of a planned ERC with planned VBAC.
Methods
Ethics Statement
Ethics approval was granted by the Children’s Youth and
Women’s Health Services Human Research Ethics Committee at
the Women’s and Children’s Hospital, and by the local
institutional review boards for each centre.
Study Design and Participants
We conducted a multicentre study at 14 Australian maternity
hospitals, all staffed and equipped to provide recommended care
for VBAC or caesarean [12–17]. Women were eligible who had a
single prior caesarean presenting in their next pregnancy with a
live singleton in cephalic presentation, at 37 wk gestation or more,
and who were considered eligible to attempt planned VBAC by
their obstetrician (Text S1) [13]. Women were ineligible with more
than one prior caesarean birth; a vertical, inverted T or unknown
uterine incision; previous uterine rupture; previous uterine surgery
(including hysterotomy or myomectomy involving entry of the
uterine cavity or excessive myometrial dissection); previous uterine
perforation; multiple pregnancy; any contraindication to vaginal
birth (including placenta praevia, transverse lie, active genital
herpes infection); cephalo-pelvic disproportion as judged by the
clinician; lethal congenital anomaly; or fetal anomaly associated
with mechanical difficulties at birth. The inclusion and exclusion
criteria were based on clinical practice guidelines for eligibility for
a VBAC [12,14–17].
In the antenatal clinic eligible women were provided with
written information about the randomised trial and patient
preference study, pamphlets on VBAC and caesarean [18,19],
and asked if they would participate by the research officer.
Recruitment started in November 2002 and was completed in
May 2007.
Randomisation, Masking, and Group Allocation
Women who gave written informed consent to the randomised
trial, were randomly assigned to either planned VBAC or planned
ERC, using a central telephone randomisation service. The
randomisation schedule was prepared by an investigator not
involved with clinical care, with stratification by centre and
previous successful vaginal birth, using balanced variable blocks.
Participants, staff, and investigators were not masked to treatment
allocation. Women who gave written informed consent to the
preference study were asked their preference for either planned
VBAC or planned ERC, and were assigned to their preferred
study group. Baseline information, including age, parity, marital
status, body mass index (BMI), socioeconomic status (SES),
psychological wellbeing, quality of life, and ethnicity self-reported
by the participant was collected to compare the study groups.
Interventions
Planned VBAC group. Participating clinicians agreed to
follow the study protocol for intrapartum care for women in the
planned VBAC group on the basis of clinical practice guidelines
[12,14–17,20–22]. After study entry, women who planned to have
a vaginal birth awaited spontaneous onset of labour. The
attending obstetrician made assessment of the woman’s on-going
suitability for a planned VBAC.
Planned ERC group: Women who planned to have an ERC
had this scheduled between 38 wk and 40 wk, preferably at 39 wk.
If a woman in the planned ERC group entered labour prior to the
scheduled elective surgical procedure, a caesarean was considered
as an emergency.
Outcomes
Study outcomes were important established measures of term
infant morbidity and maternal morbidity, up to the time of
primary hospital discharge after birth collected by trained research
personnel. The primary prespecified outcome for this study was a
composite of death or serious outcome for the infant defined as:
death (any fetal death after study entry or death of a liveborn
infant before hospital discharge [excluding lethal congenital
anomalies]); or serious morbidity (defined as one or more of:
birth trauma [subdural or intracerebral haemorrhage, spinal cord
injury, basal skull fracture, other fracture, peripheral nerve injury
present at discharge from hospital]); seizures at ,24 h age or
requiring two or more drugs to control; Apgar score ,4 at 5 min;
cord pH,7.0 (arterial or venous cord blood) and/or cord blood
base deficit $12; neonatal encephalopathy stage 3; admission to
the neonatal intensive care unit (NICU).4 d; severe neonatal lung
disease (defined as mean airway pressure .10 and or fraction of
inspired oxygen .0.80 with need for ventilation); proven
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of life treated with antibiotics.
Secondary study outcomes related to serious outcomes for the
woman defined as one or more of: maternal death; uterine rupture
(defined as a clinically significant rupture involving the full thickness
of the uterine wall and requiring surgical repair); severe haemor-
rhage (blood loss of $1,500 ml and/or requiring blood transfusion);
hysterectomy for any complications resulting from birth; vulvar or
perineal haematoma requiring evacuation; deep vein thrombosis or
thrombophlebitis requiring anticoagulant therapy; pulmonary
embolus requiring anticoagulant therapy; pneumonia due to
infection, aspiration or other causes; adult respiratory distress
syndrome; wound infection (requiring prolongation of hospital stay
or readmission) or wound dehiscence; damage to the bladder,
ureter, or bowel requiring repair, or cervical laceration extending to
the lower uterine segment, or abnormal extension of the uterine
incision; occurrence of a fistula involving the genital tract; bowel
obstruction or paralytic ileus; pulmonary oedema; stroke (defined as
acute neurological deficit .24 h); cardiac arrest or respiratory
arrest; any other serious maternal complication related to birth (as
judgedby the adverse events committee, whileremaining masked to
group allocation and mode of birth).
Statistical Methods
Analyses were performed using intention-to-treat principles,
according to the woman’s assigned mode of birth at study entry,
with the use of SAS software, version 9.1. Initial analyses were
unadjusted. We prespecified that analyses would be adjusted for
key prognostic variables with imbalance. We therefore adjusted
analyses for maternal SES, BMI, and indication for previous
caesarean birth where possible. Binary variables were analysed
with log-binomial regression to give relative risks and 95% CIs.
Figure 1. Flow of participants in the study. Data are numbers (%).
doi:10.1371/journal.pmed.1001192.g001
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Outcome n (%), Mean ± SD, or Median and Interquartile Range
RCT Patient Preference
Planned ERC
Group (n=1,108)
Planned VBAC
Group (n=1,237)
Planned ERC
(n=10)
Planned VBAC
(n=12)
Planned ERC
(n=1,098)
Planned VBAC
(n=1,225)
Age (y) 29.064.2 32.666.2 31.165.2 30.765.1 31.165.2 30.765.1
Gestational age entry (wk) 37.6 (37.0–38.0) 38.1 (37.3–39.1) 37.4 (37.1–38.2) 37.5 (37.1–38.4) 37.4 (37.1–38.2) 37.5 (37.1–38.4)
Previous vaginal birth 1 (10.0) 5 (41.7) 143 (13.0) 188 (15.3) 144 (13.0) 193 (15.6)
Smoker 1 (10.0) 3 (25.0) 177 (16.1) 194 (15.8) 178 (16.1) 197 (15.9)
Body mass index 23.1 (21.6–26.9) 28.5 (27.1–33.4) 26.7 (22.2–32.0) 25.9 (22.3–30.8) 27.9 (23.9–32.9) 26.8 (23.5–31.4)
Ethnicity
a
Caucasian 7 (70.0) 9 (75.0) 957 (87.2) 1,038 (84.7) 964 (87.0) 1,047 (84.6)
Asian 3 (30.0) 3 (25.0) 95 (8.7) 116 (9.5) 98 (8.8) 119 (9.6)
Other 0 (0.0) 0 (0.0) 46 (4.2) 71 (5.8) 46 (4.2) 71 (5.8)
Married/de facto 9 (90.0) 10 (83.3) 908 (82.7) 989 (80.7) 917 (82.8) 999 (80.8)
Socioeconomic index
b
Low SE index (disadvantaged) 1 (10.0) 1 (8.3) 256 (23.3) 341 (27.8) 257 (23.2) 342 (27.6)
Low-mid SE index 2 (20.0) 3 (25.0) 265 (24.1) 314 (25.6) 268 (24.2) 318 (25.7)
Mid-high SE index 7 (70.0) 2 (16.7) 210 (19.1) 240 (19.6) 218 (19.7) 241 (19.5)
High SE index 0 (0.0) 6 (50.0) 367 (33.4) 330 (26.9) 365 (32.9) 336 (27.2)
Emotional wellbeing
EPDS Score 10.0 (3.0–13.0) 6.0 (5.0–14.0) 6.0 (3.0–9.0) 6.0 (3.0–10.0) 6.0 (3.0–9.0) 6.0 (3.0–10.0)
Depressed (EPDS.12) 3 (33.3) 4 (36.4) 111 (11.4) 121 (11.4) 114 (11.6) 125 (11.6)
Anxiety (STAI) 12.063.6 12.564.6 10.863.6 10.963.4 10.963.6 10.963.5
Physical functioning (SF36) 59.4629 51.1625 61.5625 62.5624 61.5625.5 62.3624.1
Role physical (SF36) 58.3645 38.6645 41.8642 43.7641 41.9641.6 43.6641.2
Bodily pain (SF36) 51.9620 52.7629 58.8622 60.4622 58.7622.4 60.3621.9
General health (SF36) 72.9623 70.4620 78.6617 79.0616 78.5616.7 78.9615.8
Vitality (SF36) 43.9619 58.2616 50.4620 51.5619 50.3619.6 51.5618.7
Social functioning (SF36) 73.6618 78.4626 76.7622 76.8622 76.7621.9 76.8621.9
Role emotional (SF36) 63.0642 75.8642 83.8632 82.1633 83.6632.2 82.0633.1
Mental health (SF36) 77.8613 69.5616 77.7615 77.0615 77.7615.0 76.9615.0
Physical component (SF36) 40.069.3 36.669.7 39.1610 40.069.6 39.169.9 39.969.6
Mental Component (SF36) 48.769.5 51.869.6 52.569.0 52.169.0 52.569.0 52.169.0
Brazier health utility (SF36) 0.760.2 0.7160.1 0.7460.1 0.7460.1 0.760.1 0.760.1
Main reasons for previous
caesarean
Failure to progress 1 (10.0) 5 (41.7) 469 (42.7) 394 (32.2) 470 (42.4) 399 (32.3)
Fetal distress 6 (60.0) 8 (66.7) 423 (38.5) 467 (38.1) 429 (38.7) 475 (38.4)
Breech 2 (20.0) 1 (8.3) 217 (19.8) 411 (33.6) 219 (19.8) 412 (33.3)
Cephalopelvic disproportion 1 (10.0) 1 (8.3) 81 (7.4) 64 (5.2) 82 (7.4) 65 (5.3)
Failed induction 2 (20.0) 1 (8.3) 46 (4.2) 59 (4.8) 48 (4.3) 60 (4.9)
Antepartum haemorrhage 1 (10.0) 1 (8.3) 42 (3.8) 60 (4.9) 43 (3.9) 61 (4.9)
Maternal choice 0 (0.0) 0 (0.0) 73 (6.6) 32 (2.6) 73 (6.6) 32 (2.6)
Maternal medical disorder 0 (0.0) 2 (16.7) 31 (2.8) 24 (2.0) 31 (2.8) 26 (2.1)
Pre-eclampsia/eclampsia 1 (10.0) 0 (0.0) 66 (6.0) 63 (5.1) 67 (6.0) 63 (5.1)
Other 1 (10.0) 1 (8.3) 65 (5.9) 63 (5.1) 66 (6.0) 64 (5.2)
aEthnicity as reported by the participant.
bSocioeconomic index as measured by SEIFA where high index scores indicate increasing levels of social disadvantage.
EPDS, Edinburgh Postnatal Depression Scale [32]; SD, standard deviation; SE, socioeconomic; STAI, Spielberger State-Trait Anxiety Inventory [33]; SF3, SF36-Health
Survey Questionnaire [34].
doi:10.1371/journal.pmed.1001192.t001
Planned VBAC or ERC: Health Outcomes
PLoS Medicine | www.plosmedicine.org 4 March 2012 | Volume 9 | Issue 3 | e1001192Continuous variables, if normally distributed, were analysed with a
Student’s t-test, and nonparametric tests were used for skewed
data. We tested for interaction between treatment groups (VBAC
and ERC) by study arm (randomised and patient preference) by
calculating 95% CIs on the basis of the score method for the
difference in treatment of the outcome proportions for binary data
[23]. For all outcomes, apart from emergency caesarean where
results are presented separately, no interactions were detected and
the results of the preference and randomised arms were combined.
The difference of proportions metric was used, as the number of
women in the randomised arm was small generating zero cells.
Consequently the relative risk was undefined for some outcomes.
A p-value of less than 0.05 was considered to indicate statistical
significance (2-sided). An interim analysis was not performed.
Sample Size
We estimated that a sample size of 2,314 women would have
statistical power of 80% (two-tailed alpha level 0.05) to detect an
increase of 2% in the risk of fetal death or liveborn infant death
prior to discharge or serious infant outcome from 1.6% for
planned ERC [24] to 3.6% for planned VBAC (Text S1) [13].
Results
Of the 2,345 women enrolled, 1,108 (47.2%) were in the
planned ERC group (ten randomised; 1,098 patient preference)
and 1,237 (52.8%) in the planned VBAC group (12 randomised;
1,225 patient preference) (Figure 1). Clinical outcomes to primary
hospital discharge after birth were available for all women and
their infants.
The two treatment groups were similar at the time of study
entry apart from women in the planned ERC group compared
with women in the VBAC group being of slightly higher BMI, and
SES, and there were some differences in the reasons for the
previous caesarean section (Table 1).
Primary Outcomes
The risk of fetal or liveborn infant death prior to discharge or
serious outcome was significantly reduced for infants born to
women in the planned ERC group compared with infants of
women in the planned VBAC group (planned ERC 10/1,108
[0.9%] versus planned VBAC 30/1,237 [2.4%], relative risk [RR]
0.39, 95% CI 0.19–0.80, p=0.011) (Table 2). The number needed
to treat to benefit with planned ERC to prevent fetal death or
Table 2. Primary outcomes.
Outcome RCT Patient Preference
Planned ERC
Group (n=1,108)
Planned VBAC
Group (n=1,237)
Adjusted RR
(95% CI)
a
p-
Value
Planned
ERC
(n=10)
Planned
VBAC
(n=12)
Planned
ERC
(n=1,098)
Planned
VBAC
(n=1,225)
n Percent n Percent n Percent n Percent n Percent n Percent CI Range
Death or serious infant
outcome
b
0 (0.0) 0 (0.0) 10 (0.9) 30 (2.4) 10 (0.9) 30 (2.4) 0.39 (0.19–
0.80)
0.011
Perinatal death 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.2) 0 (0.0) 2 (0.2) 0.50
Stillbirth 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.2) 0 (0.0) 2 (0.2)
Neonatal death 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Serious neonatal
morbidity
0 (0.0) 0 (0.0) 10 (0.9) 28 (2.3) 10 (0.9) 28 (2.3) 0.41 (0.20–
0.83)
0.014
Birth trauma 0 (0.0) 0 (0.0) 0 (0.0) 3 (0.2) 0 (0.0) 3 (0.2) 0.25
Seizures 0 (0.0) 0 (0.0) 1 (0.1) 1 (0.1) 1 (0.1) 1 (0.1) 1.11 (0.07–
17.8)
1.00
Apgar #4 at 5 min 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 1 (0.1) 1.00
Cord pH,7.0 0 (0.0) 0 (0.0) 1 (0.1) 6 (0.5) 1 (0.1) 6 (0.5) 0.19 (0.02–
1.54)
0.13
Cord blood base deficit
$12 mmol/l
0 (0.0) 0 (0.0) 1 (0.1) 9 (0.7) 1 (0.1) 9 (0.7) 0.13 (0.02–
1.06)
0.06
Stage 3 encephalopathy 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
NICU admission .4 d 0 (0.0) 0 (0.0) 4 (0.4) 7 (0.6) 4 (0.4) 7 (0.6) 0.64 (0.18–
2.25)
0.48
Severe lung disease 0 (0.0) 0 (0.0) 2 (0.2) 1 (0.1) 2 (0.2) 1 (0.1) 2.23 (0.20–
24.6)
0.61
Necrotising enterocolitis 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Proven systemic
infection
0 (0.0) 0 (0.0) 1 (0.1) 4 (0.3) 1 (0.1) 4 (0.3) 0.28 (0.03–
2.49)
0.38
aValues adjusted for maternal SES, BMI, and indication for previous caesarean birth.
bDeath or serious outcome includes: death (any fetal death after study entry or death of a liveborn infant prior to hospital discharge [excluding lethal congenital
anomalies]); or serious neonatal morbidity (defined as one or more of: birth trauma [subdural or intracerebral haemorrhage, spinal cord injury, basal skull fracture, other
fracture, peripheral nerve injury present at discharge from hospital]; seizures at ,24 h age or requiring two or more drugs to control; Apgar score ,4 at 5 min; cord
pH,7?0; cord blood base deficit $12 mmol/l; neonatal encephalopathy stage 3; admission to NICU.4 d; severe neonatal lung disease [defined as MAP.10 and or
FiO2.0?80 with need for ventilation]; proven necrotising enterocolitis; or proven systemic infection in first 48 h of life treated with antibiotics).
NICU, neonatal intensive care unit.
doi:10.1371/journal.pmed.1001192.t002
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infant was 66 (95% CI 40–200).
When the individual components of the primary endpoint were
examined there was a statistically significant reduction in the
risk of serious morbidity for infants born to women in the
planned ERC group, compared with infants born to women in the
planned VBAC group (planned ERC 10/1,108 [0.9%]
versus planned VBAC 28/1,235 [2.3%], RR 0.41, 95% CI
0.20–0.83, p=0.014). There were no statistically significant
differences identified for any of the other individual components
of the primary outcome between the two treatment groups.
No perinatal deaths occurred among infants of mothers in the
planned ERC group. There were two stillbirths in the planned
VBAC group. Both infants were born at 39 wk. The cause of
death after autopsy for both infants was unexplained stillbirth.
Secondary Outcomes
There were no maternal deaths in this study. The risk of
maternal death or serious morbidity for women in the planned
ERC group was 3.1% (34/1,108) and 4.5% (56/1,237) for women
in the planned VBAC group; this was not a statistically significant
difference (RR 0.69, 95% CI 0.46–1.05, p=0.08). When the
individual components of the composite outcome were examined,
significantly fewer women in the planned ERC group had a major
haemorrhage (defined as blood loss .1, 500 ml and/or need for
blood transfusion) when compared with planned VBAC (planned
Table 3. Secondary maternal outcomes by planned mode of birth.
Outcome RCT Patient Preference
Planned ERC
Group (n=1,108)
Planned VBAC
Group (n=1,237)
Adjusted RR
(95% CI)
a
p-
Value
Planned ERC
(n=10)
Planned
VBAC (n=12)
Planned ERC
(n=1,098)
Planned VBAC
(n=1,225)
n Percent n Percent n Percent n Percent n Percent n Percent CI Range
Serious maternal
outcome
b
0 (0.0) 0 (0.0) 34 (3.1) 56 (4.6) 34 (3.1) 56 (4.5) 0.69 (0.46–
1.05)
0.08
Maternal death 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Uterine rupture 0 (0.0) 0 (0.0) 1 (0.1) 3 (0.2) 1 (0.1) 3 (0.2) 0.37 (0.04–
3.57)
0.63
Major
haemorrhage
.1500 ml
0 (0.0) 0 (0.0) 9 (0.8) 29 (2.4) 9 (0.8) 29 (2.3) 0.37 (0.17–
0.80)
0.011
Hysterectomy 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 1 (0.1) 1.0
Vulval/perineal
haematoma
0 (0.0) 0 (0.0) 1 (0.1) 2 (0.2) 1 (0.1) 2 (0.2) 0.56 (0.05–
6.15)
1.0
DVT requiring
anticoagulation
0 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 1 (0.1) 0 (0.0) 0.47
PE requiring
anticoagulation
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Pneumonia 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Adult respiratory
distress
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Wound infection/
dehiscence
0 (0.0) 0 (0.0) 18 (1.6) 13 (1.1) 18 (1.6) 13 (1.1) 1.62 (0.77–
3.40)
0.20
Organ damage
requiring repair
0 (0.0) 0 (0.0) 6 (0.5) 15 (1.2) 6 (0.5) 15 (1.2) 0.46 (0.17–
1.20)
0.11
Genital tract
fistula
0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 1 (0.1) 1.0
Bowel
obstruction/ileus
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Pulmonary
oedema
0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 1 (0.1) 1.0
Stroke 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Cardiac arrest 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Respiratory arrest 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
aValues adjusted for maternal SES, BMI, and indication for previous caesarean birth.
bDeath or serious maternal outcome includes: one or more of maternal death; uterine rupture (defined as a clinically significant rupture involving the full thickness of
the uterine wall and requiring surgical repair); severe haemorrhage (blood loss of $1,500 ml and/or requiring blood transfusion); hysterectomy for any complications
resulting from birth; vulval or perineal haematoma requiring evacuation; deep vein thrombosis (DVT) or thrombophlebitis requiring anticoagulant therapy; pulmonary
embolus (PE) requiring anticoagulant therapy; pneumonia due to infection, aspiration or other causes; adult respiratory distress syndrome; wound infection (requiring
prolongation of hospital stay or readmission) or wound dehiscence; damage to the bladder, ureter, or bowel requiring repair, or cervical laceration extending to the
lower uterine segment, or abnormal extension of the uterine incision; occurrence of a fistula involving the genital tract; bowel obstruction or paralytic ileus; pulmonary
oedema; stroke (defined as acute neurological deficit .24 h); cardiac arrest; respiratory arrest.
doi:10.1371/journal.pmed.1001192.t003
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RR 0.37, 95% CI 0.17–0.80, p=0.011, NNTB 66, 95% CI 40–
187). There were no statistically significant differences between the
treatment groups for any of the other secondary outcomes
(Table 3).
In the planned ERC group 1,083 (97.7%) women gave birth by
caesarean section, with the majority (87.6%) as an elective
procedure. In the planned VBAC group 535 (43.2%) women
had a vaginal birth and 702 (56.8%) had a caesarean section; 334
(27.0%) as an elective and 368 (29.7%) as an emergency procedure
(Table 4). The main indications for caesarean section in the
planned VBAC group were previous caesarean section, failure to
progress, and fetal distress. Women in the planned ERC group
compared with women in the planned VBAC group gave birth at
an earlier gestational age and although their median length of
postnatal hospital stay was longer they were not more likely to stay
more than 7 d (Table 4).
Discussion
In this study involving women with a single prior caesarean
who had reached 37 wk gestation in their next pregnancy, and
who did not have a contraindication to a planned VBAC, a plan
to birth by ERC was associated with a beneficial reduction in the
risk of fetal death or liveborn infant death prior to discharge or
serious outcome for the infant, when compared with women who
planned VBAC. For women planning a VBAC our 2.4% risk of
death or serious outcome for the infant is similar to that reported
from previous cohort studies that compared actual rather than
planned mode of birth where risks ranged between 0.13% and
2.4% [4,9].
There are a number of strengths to our study design,
enhancing the validity of our results. To our knowledge, this is
the first randomised trial to report on health outcomes in this
setting. However, few women consented to the randomised
trial, as was suggested likely by our pre-trial survey of women’s
views [25]. Although the randomised controlled trial is
regarded as the ‘‘gold standard’’ research methodology for
assessing the effects of health care interventions, some research
questions cannot be fully answered using this design,
particularly where patients have strong treatment preferences,
and decline randomisation as in our setting. Given our
experience here and the recognised difficulty of recruitment
to randomised trials related to VBAC [9,11], it seems unlikely
that large randomised trials will be conducted, although these
may still be possible in other health care settings.
This is the first study designed around women’s planned
preferences for birth after caesarean, among women who were
eligible for a VBAC, and therefore provides a high quality estimate
of the benefits and harms associated with the two planned or
Table 4. Labour and birth outcomes.
Outcome n (%), Mean ± SD, or Median and Interquartile Range
Adjusted RR (95%
CI)
a p-Value
RCT Patient Preference
Planned ERC
Group
(n=1,108)
Planned VBAC
Group (n=1,237)
Planned
ERC
(n=10)
Planned
VBAC
(n=12)
Planned
ERC
(n=1,098)
Planned
VBAC
(n=1,225) CI Range
Gestational age at
birth (wk)
39.260.7 40.061.0 38.860.7 40.061.1 38.860.7 40.061.1 21.1 (21.2 to 1.01) ,0.001
Induction of labour 0 (0.0) 2 (16.7) 4 (0.4) 151 (12.3) 4 (0.4) 153 (12.4) 0.03 (0.01–0.08) ,0.001
Mode of birth
Vaginal birth 2 (20.0) 7 (58.3) 23 (2.1) 528 (43.1) 25 (2.3) 535 (43.2) 0.06 (0.04–0.09) ,0.001
Caesarean section 8 (80.0) 5 (41.7) 1,075 (97.9) 697 (56.9) 1,083 (97.7) 702 (56.8) 1.67 (1.59–1.75) ,0.001
Elective caesarean
section
5 (50.0) 4 (33.3) 966 (88.0) 330 (26.9) 971 (87.6) 334 (27.0) 3.10 (2.82–3.42) ,0.001
Emergency caesarean
section
Preference arm 109 (9.9) 367 (30.0) 109 (9.9) 367 (30.0) 0.32 (0.27–0.40) ,0.001
Randomised arm 3 (30.0) 1 (8.3) 3 (30) 1 (8.3) 3.60 (0.44–29.5) 0.19
Analgesia/anaesthesia 9 (90.0) 12 (100) 1,080 (98.4) 1,148 (93.7) 1,089 (98.3) 1,160 (93.8) 1.04 (1.02–1.06) ,0.001
Epidural 3 (30.0) 4 (33.3) 183 (16.7) 425 (34.7) 186 (16.8) 429 (34.7) 0.47 (0.41–0.55) ,0.001
Postpartum haemorrhage
.500 ml
2 (20.0) 2 (16.7) 184 (16.8) 214 (17.5) 186 (16.8) 216 (17.5) 0.91 (0.76–1.09) 0.30
Postpartum infection 0 (0.0) 0 (0.0) 4 (0.4) 3 (0.2) 4 (0.4) 3 (0.2) 1.49 (0.33–6.64) 0.71
Length of stay (d) 5 (3–5) 4 (3–5) 5 (4–6) 4 (3–5) 5 (4–6) 4 (3–5) ,0.001
Length of stay .7 d 0 (0.0) 0 (0.0) 60 (5.5) 62 (5.1) 60 (5.4) 62 (5.0) 1.08 (0.76–1.54) 0.67
Infant birthweight (g) 3,4016475 3,5346425 3,4626451 3,5716495 3,4626451 3,5716494 256 (2252 to
139.4)
0.57
Apgar score ,7 at 5 min 0 (0.0) 0 (0.0) 3 (0.3) 8 (0.7) 3 (0.3) 8 (0.6) 0.48 (0.12–1.86) 0.29
aValues adjusted for maternal SES, BMI, and indication for previous caesarean birth.
RCT, randomised controlled trial.
doi:10.1371/journal.pmed.1001192.t004
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Most of the previous evidence has been based on comparison of
actual mode of birth where groups were less comparable [11].
Information relating to health outcomes for women and their
infants is known for all 2,345 women enrolled in the study, and our
sample size was sufficiently large to allow us to detect important,
small differences between the two policies for care.
Flaws identified in the literature related to the risks and benefits
of planned ERC and planned VBAC have included a lack of
comparability of groups, specifically being unclear whether women
included in the ERC group were truly eligible to attempt VBAC
[10]. Our study methodology ensured that all women recruited
were considered eligible to attempt VBAC, on the basis of current
clinical practice guidelines, as assessed by qualified staff at the time
of study entry. We made a comprehensive assessment of known
confounders with statistical adjustments for minor imbalances
found between treatment groups for BMI, SES, and indication for
previous caesarean. Nevertheless, unmeasured confounding may
still account in part for the study findings. Our intention-to-treat
analysis ensured that the study evaluated a policy of choice around
planned ERC and planned VBAC.
We identified no increase in the risk of short-term maternal
morbidity related to planned ERC, but rather a beneficial
reduction in the risk of major maternal haemorrhage and/or the
need for blood transfusion compared with planned VBAC. This
finding is in sharp contrast to other reports where ERC has been
associated with an increase in maternal blood loss [4,26] and
justifies further study.
The risk of symptomatic uterine scar rupture was low for both
treatment groups being 0.1% for women in the planned ERC
group and 0.2% for women in the planned VBAC group. This risk
of uterine rupture related to VBAC is lower than that reported
from the NICHD cohort study of 0.7% [4] and lower than the rate
of symptomatic uterine scar rupture of 1.2/100 to 3.9/1,000
among women having a VBAC reported in systematic reviews of
other cohort studies [9–11]. The standardised treatment schedules
for VBAC and ERC, based on relevant evidence-based clinical
practice guidelines used by all participating hospitals, may account
for the low rates observed.
There is a well-documented increase in the risk of both perinatal
mortality and infant morbidity with increasing gestational age
beyond term [27,28]. The differences in the risk of death or serious
outcome for infants born to women in the planned VBAC group
could be related to the difference in gestational age at birth
observed between the two groups, rather than planned mode of
birth. The relationship between advancing gestational age and
morbidity and mortality, and the optimal time of birth for women
at term therefore warrants further prospective evaluation.
Although statistically significant, overall the absolute risk
difference in adverse health outcomes between the two forms of
care remains small. Nevertheless, these small differences in the risk
of short-term adverse health outcomes, either for the women or for
their infants, are likely to be of considerable importance to the
women, and therefore influence their choice of preferred mode of
birth [29]. Absolute risk differences (related to mode of birth) may
vary by factor, such as previous successful vaginal birth, where
planned VBAC is more likely to result in vaginal birth. Similar
proportions of women in each treatment group had achieved a
previous vaginal birth prior to the caesarean (13% in the planned
ERC group and 15.6% in the planned VBAC group). There have
been no studies comparing the risks and benefits of VBAC with
ERC that have reported on the health outcomes beyond the
neonatal period. This lack of information on long-term health of
either VBAC or ERC should be included in the counselling
provided to women to assist with their decision making.
There is a need to establish whether the identified short-term
benefits in health and wellbeing persist or are balanced by later
risks. Therefore the evaluation of longer-term health, for both the
women and children in this study, will be important. Our planned
longer-term follow-up at early school age will assess maternal and
child health as well as outcome in subsequent pregnancies
including the risk from multiple caesareans, such as placenta
praevia and accreta, and fertility [11,12].
Our ‘‘restricted’’ prospective cohort study design used method-
ological features of high quality randomised trials, which included
identification of a ‘‘zero time’’ for determining eligibility, study
entry, and baseline characteristics; use of inclusion and exclusion
criteria; treatment protocols derived from evidence-based clinical
practice guidelines; standardised definitions for clinical outcomes;
adjustment for imbalance in confounders at study entry; and the
use of intention-to-treat analyses [30,31].
Our results, whilst not generalisable for other populations,
indicate that for women who have had one previous caesarean
birth and are considered eligible at term to attempt a planned
VBAC in their next pregnancy, an ERC as planned mode of birth
is significantly associated with a lower risk of both fetal death or
liveborn infant death prior to discharge or serious infant morbidity
and major maternal haemorrhage without increasing other
maternal and perinatal complications. Women, clinicians, and
policy makers can use this information to develop health advice to
assist in making evidence-based decisions about care for women
who have had a previous caesarean and their infants.
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Background. Rates of caesarean section are rising around
the world, particularly in high- and middle-income countries,
where most women have a choice of how their baby is
delivered. Historically, the obstetrician in charge of the
woman’s care made the decision on whether to perform an
elective (planned) caesarean section based on medical
criteria. For women who have had a previous caesarean
section, typically, their options for mode of childbirth are
either a trial of vaginal birth or an elective repeat caesarean
section. The proportion of women attempting a vaginal birth
after a previous caesarean section has been declining in
many countries partly due to the variable chance of
achieving a successful vaginal birth (reported between 56%
and 80%) and partly because of negative reports of the risk
of complications, both to the mother and the baby, of a
having a vaginal delivery following a caesarean section.
Consequently, the rates of repeat caesarean section have
risen sharply, for example, currently 83% in Australia and
almost 90% in the US.
Why Was This Study Done? Both elective repeat
caesarean section and subsequent vaginal delivery after a
previous caesarean section have clinical risks and benefits.
Most obviously, having a surgical procedure puts the woman
having the repeat caesarean section at risk of surgical
complications, especially if performed under a general
anesthetic, and her baby may be at risk of respiratory
complications. However, subsequent vaginal delivery
following a previous caesarean section may put the
mother at risk of bleeding severely enough to need a
blood transfusion (more than 1,500 ml blood loss) and she
may also be at increased risk of rupturing her uterus; and her
baby may have an increased risk of dying or of becoming
brain damaged due to lack of oxygen.
However, to date there have been no randomized controlled
trials of elective repeat caesarean section versus vaginal
delivery following a previous caesarean section to compare
the health outcomes of mother and baby and a recent
systematic review could draw no conclusions. So the
researchers conducted this prospective cohort study based
on patient preference (with a few women agreeing to be
randomized to mode of delivery), to compare the health
outcomes for mother and baby for elective repeat caesarean
section versus vaginal delivery in women following a
previous caesarean section.
What Did the Researchers Do and Find? Between 2002
and 2007, the researchers recruited 2,345 suitable women
(that is, women who had one previous caesarean section,
were currently 37 weeks pregnant with a single baby, and
who were clinically able to have a vaginal delivery) from 14
maternity hospitals throughout Australia. A few women (22)
agreed to be randomized to either mode of delivery but
most women chose her preferred option. Then, depending
on the woman’s preferences for mode of birth, participating
obstetricians either scheduled a date for an elective
caesarean section (1,098 women) or assessed on-going
suitability for the woman to have a planned vaginal
delivery (1,225 women). However only 535 (43.2%) women
who chose to have a vaginal birth were able to deliver this
way because of failure to progress in labor or fetal distress:
334 of these women (27.0%) had to have an elective
caesarean section and 368 women had to have an
emergency caesarean section.
Although no women died, women who had a planned
caesarean section experienced less severe bleeding than
women who delivered vaginally. There were no infant deaths
in those born by elective caesarean section but two
unexplained stillbirths in the planned vaginal delivery group.
There was also a reduced risk of nonfatal serious outcome
before discharge from hospital for infants delivered by in the
elective caesarean section. The researchers calculated that
one infant death or near death would be prevented for every
66 elective caesarean sections performed in women who had
a previous caesarean section.
What Do These Findings Mean? These findings show
that in women who had delivered by a previous caesarean
section delivering their next baby by planned caesarean
section was associated with less infant death and better
health outcomes for the mother before she was discharged
from the hospital compared to women who had a
subsequent vaginal delivery. This information can be used
by women, clinicians, and policy makers in helping to make
decisions about the mode of subsequent deliveries and best
care for women who have had a previous caesarean section.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001192.
N This study is linked to a PLoS Medicine Research Article by
Fitzpatrick and colleagues and a PLoS Medicine Perspective
by Catherine Spong
N The American Congress of Obstetricians and Gynecologists
has information sheets for patients on caesarean sections
and on vaginal birth after caesarean delivery
N Childbirth Connection, a US-based not-for-profit organiza-
tion, provides information about caesarean sections and
about vaginal birth after caesarean
N The National Childbirth Trust, a UK charity, provides
information for parents on all aspects of pregnancy and
birth, including caesarean sections and vaginal birth after
caesarean delivery
N The UK charity Healthtalkonline has personal stories from
women making decisions about birth after a caesarean
section
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